Liquid polymer composition and method of use

Details Liquid polymer composition and method of use Liquid polymer composition and method of use

1995-04-25

1997-07-15

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Designated organic nonactive ingredient containing other...

Solid synthetic organic polymer

514773, 514777, 514784, 514902, 424 49, 424 54, 424434, 424435, 424487, A61K 600

Patent

active

056483996

ABSTRACT:
The invention relates to methods for the treatment of gingivitis, oral plaque and oral or dermatological fungal infections by the administration of a liquid methacrylic acid copolymer composition that contains a release adjusting agent and a pharmacological agent. The composition forms a solid film upon drying, and is capable of accomplishing the sustained release of the pharmacological agent such as to permit its use in the treatment or prevention of dental or dermatological conditions.

REFERENCES:
patent: 2984639 (1961-05-01), Stamberger et al.
patent: 3312594 (1967-04-01), Cry et al.
patent: 3325402 (1967-06-01), Erskine
patent: 3431208 (1969-03-01), Bailey et al.
patent: 3703583 (1972-11-01), Martin
patent: 3846542 (1974-11-01), Gross
patent: 3925895 (1975-12-01), Kliment et al.
patent: 3956480 (1976-05-01), Dichter et al.
patent: 4011309 (1977-03-01), Lutz
patent: 4057621 (1977-11-01), Pashley et al.
patent: 4339430 (1982-07-01), Gaffar
patent: 4374824 (1983-02-01), Wahmi
patent: 4415549 (1983-11-01), Shah et al.
patent: 4459277 (1984-07-01), Kosti
patent: 4517173 (1985-05-01), Kizawa et al.
patent: 4539199 (1985-09-01), Orban et al.
patent: 4554156 (1985-11-01), Fischer et al.
patent: 4569837 (1986-02-01), Suzuki et al.
patent: 4634589 (1987-01-01), Scheller
patent: 4645662 (1987-02-01), Nakashima et al.
patent: 4683134 (1987-07-01), Palinczar
patent: 4701320 (1987-10-01), Hasegawa et al.
patent: 4710372 (1987-12-01), Scheller
patent: 4725440 (1988-02-01), Ridgeway et al.
patent: 4751072 (1988-06-01), Kim
patent: 4775525 (1988-10-01), Pera
patent: 4876092 (1989-10-01), Mizobuchi et al.
patent: 4883534 (1989-11-01), Sandham et al.
patent: 4911922 (1990-03-01), Masuhara et al.
patent: 4925660 (1990-05-01), Atsuta et al.
patent: 4957730 (1990-09-01), Bohn et al.
patent: 4963347 (1990-10-01), Humphries et al.
patent: 5002769 (1991-03-01), Friedman
patent: 5023082 (1991-06-01), Friedman et al.
patent: 5160737 (1992-11-01), Friedman et al.
patent: 5330746 (1994-07-01), Friedman et al.
patent: 5438076 (1995-08-01), Friedman et al.
Addy, M. and J. Llewelyn, "Use of chlorhexidine gluconate and povidone ioe mouthwashes in the treatment of acute ulcerative gingivitis," J. Clin. Periodontol. 5:272-277 (1978).
Addy, M. and L. Hunter, "The effects of a 0.2% chlorhexidine gluconate mouth rinse on plaque, toothstaining and candida in aphthous ulcer patients: A double-blind placebo-controlled cross-over study," J. Clin. Periodontol. 14:267-273 (May 1987).
Afflitto, J. et al., "Effects of Tetrapotassium Peroxydiphosphate (KPDP) on Plaque/Gingivitis in Vivo," J. Dent. Res. 67:401, Abstract 2309 (Mar. 1988).
Bossche, H. V. et al., "Anti-Candida Drugs--The Biochemical Basis for Their Activity," Crit. Rev. Microbiol. 15(1):57-72 (Nov. 1987).
Cameron, J. A., "The use of ultrasound and an EDTA-urea peroxide compound in the cleansing of root canals. An SEM study," Australian Dent. J. 29(2):80-85 (1984).
Chafi, N. et al., "Preparation and Study of Oral Galenic Forms by Dispersing into Eudragit/Matrix a Polyacryloyl-Acetylsalicylic Anhydride," Drug Dev. Industrial Pharm. 15(4):629-648 (Apr. 1989).
Chivian, N., "Endodontics: An Overview," Dent. Clinics N. Amer. 28(4):637-649 (1984).
Cianico, S. G. et al., "The Effect of a Quaternary Ammonium-Containing Mouthwash on Formed Plaque," Pharmacol. Ther. Dent. 3:1-6 (1978).
Dittgen, M. et al., "Untersuchung von Polyacrylat-und Polymethacrylathydrogelen," Pharmazie 41:883-884 (1986).
Translation of Dittgen, M. et al., "Untersuchung von Polyacrylat-und Polymethacrylathydrogelen," Pharmazie 41:883-884 (1986) (document AR4).
Friedman, M. et al., "Sustained Release Chlorhexidine Preparations for Topical Use," IADR Abstr. p. 905, Abstract 72 (1980).
Friedman, M. and G. Golomb, "New sustained release dosage form of chlorohexidine for dental use," J. Periodontal Res. 17:323-328 (1982).
Friedman, M. et al., "Plaque Inhibition by Sustained Release of Chlorhexidine from Removable Appliances," J. Dent. Res. 64(11):1319-1321 (1985).
Kostiala, I. et al., "Oral mycoses and their treatment," Acta Ondontol. Scand. 37:87-101 (1979).
Rohm Pharma GmbH, "Technical Application Pamplet (Info L/S-13/e) Eudragit.RTM. L/S", Weiterstadt, Germany Jan. 1991.
Rohm Pharma GmBh, Manufacturer's Listing of Different Types of Eudragit.TM., Weiderstadt, Germany Jan. 1991.
Rohm Pharma GmBh, "Standards Sheet (Info L/S-7a/e) Eudragit.RTM. L/S", Weiderstadt, Germany Jan. 1970.
Rohm Pharma GmBh, "Eudragit.TM. RL and RS Application in the Production of Pharmaceutical Preparations" Jan. 1970.
Soskolone, A. et al., "New sustained release dosage form of chlorhexidine for dental use," J. Periodontal Res. 18:330-336 (1983).
Von W. Kern, B. et al., in: Hagers Handbuch Der Pharmazeutischen Praxis, Springer-Verlag: Berlin, pp. 402-403 (1977).
Translation of Von W. Kern, B. et al., in: Hagers Handbuch Der Pharmazeutischen Praxis, Springer-Verlag: Berlin, pp. 402-403 (1977) (document AS9).
Derwent English Language abstract for DE 35 44983 (document AN4), WPI Acc. No. 87-178557/26 Jan. 1996.
Derwent English Language abstract for EP 0 264 660 (document AL5), WPI Acc. No. 88-113365/17 Apr. 1988.
Derwent English Language abstract for JP 60 228410, WPI Acc. No. 86-003017/01 Feb. 1994.
Derwent English Language abstract for JP 63 044518 (documnt AO4), WPI Acc. No. 88-094610/14 Feb. 1994.
Derwent English Language abstract for DE 2 332 383 (Document AL2), WPI Acc. No. 74-04404V/03 Jan. 1996.
Derwent Enlgish Language abstract for JP 63 60924 (Document AO4), WPI Acc. No. 88-092984 Jan. 1996.
Chang, R.K., et al., "Preparation and Preliminary Evaluation of Eudragit RL and RS Pseudolatices for Controlled Drug Release," Drug Development and Industial Pharmacy 15(3:361-372 (1989).
Goodson, J.M., et al., Medical Applications of Controlled Release, vol. II, Langer, R.S. et al. (eds.), West Palm Beach, FL: CRC Press, Inc., pp. 115-138 (1984).
Goto, S., et al., "Evaluation of the Sustained Release Properties of Eudragit RS, RL and S (acrylic resins) Microencapsule Containing Ketoprofen in Beagle Dogs," J. Microcapsulation 5:343-360 (Oct.-Dec. 1988).
Kristl, J. et al., "Physikalische Eiqenschaften von Eudispert-Poly-elektrolytsystemen und ihre In-Vitro-Wirkstoffliberation," Acta Pharm. Technol. 33(30): 140-144 (Sep. 1987).
Translation of Kristl, J. et al., "Physikalische Eiqenschaften von Eudispert-Poly-elektrolytsystemen und ihre In-Vitro-Wirkstoffliberation," Acta Pharm. Technol. 33(3): 140-144 (Sep. 1987) (Ref. AT6).
Thoennes, C.J., et al., "Evaluation of a Rapidly Disintegrating Moisture Resistant Lacquer Film Coating," Drug Development and Industrial Pharmacy 15(2):165-185 (1989).
Wood, D.A., et al., "Biodegradable Drug Delivery Systems," International J. of Pharmaceutics 7:1-18 (1980).
Derwent Abstract for German Patent Document No. 3720147 (Ref. AO5), WPI Acc. No.89-008242 Jun. 1987.
Derwent Abstract for the Patent Family of European Patent Document No.EP 0298271 (Ref. AP5), WPI Acc. No. 89-008242.

Affiliated with

Also associated with

Rating

Liquid polymer composition and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liquid polymer composition and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid polymer composition and method of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1492719